| 1 |
32897512 | Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761. | 2022 Apr |
1 |
| 2 |
35093870 | Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment. | 2022 Feb |
1 |
| 3 |
33589792 | Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population. | 2021 Apr |
7 |
| 4 |
34500231 | TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway. | 2021 Dec |
1 |
| 5 |
31624332 | ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide. | 2020 Apr |
3 |
| 6 |
33123485 | Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. | 2020 |
2 |
| 7 |
31409725 | MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. | 2019 Sep 30 |
1 |
| 8 |
29520610 | ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma. | 2018 Jul |
1 |
| 9 |
29779087 | Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model. | 2018 Sep |
1 |
| 10 |
30254183 | Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma. | 2018 Dec |
6 |
| 11 |
30562739 | Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity. | 2018 |
1 |
| 12 |
28380412 | β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1. | 2017 Jun |
2 |
| 13 |
26136652 | Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme. | 2015 |
1 |
| 14 |
26447477 | Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. | 2015 |
1 |
| 15 |
27158638 | Temozolomide resistance and tumor recurrence: Halting the Hedgehog. | 2015 |
1 |
| 16 |
23771630 | Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling. | 2014 Feb |
1 |
| 17 |
24647572 | ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. | 2014 May 15 |
3 |
| 18 |
23897632 | Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway. | 2013 Nov |
5 |
| 19 |
18687982 | A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. | 2009 Jan |
10 |